Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIA-1 Catheter (542-1)

K-Number: K251402 · 2025-12-19

Decision Date2025-12-19
Product CodeKTI
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

LIA-1 Catheter (542-1) is the device name listed in this FDA 510(k) record. The listed applicant is Leadoptik, Inc.. It received FDA 510(k) clearance on 2025-12-19 under 510(k) number K251402. The device is classified under product code KTI. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIA-1 Catheter (542-1)?

LIA-1 Catheter (542-1) is a medical device that received FDA 510(k) clearance on 2025-12-19. The listed applicant is Leadoptik, Inc.. The 510(k) number is K251402.

When did LIA-1 Catheter (542-1) receive FDA 510(k) clearance?

LIA-1 Catheter (542-1) received FDA 510(k) clearance on 2025-12-19, under 510(k) number K251402.

Who is the listed applicant for LIA-1 Catheter (542-1)?

The FDA 510(k) record lists Leadoptik, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIA-1 Catheter (542-1)?

The FDA product code for LIA-1 Catheter (542-1) is KTI.

Other records listing Leadoptik, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KTI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.